Haptoglobin fucosylation in ascites fluids of ovarian cancer patients

Advances in Clinical and Experimental Medicine

Volumn 13, Issue 4, 2004, Pages 581-587

  Ferens Sieczkowska, Mirosława ^a   Kossowska, Barbara ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Ascites fluids; Fucosylation; Haptoglobin; Lewisx

Indexed keywords

EPITOPE; FUCOSE; HAPTOGLOBIN; LECTIN; MONOCLONAL ANTIBODY; SIALIC ACID; SIALYL LEWIS X ANTIGEN;

ADULT; ADVANCED CANCER; ANTIGEN EXPRESSION; ANTIGEN STRUCTURE; ARTICLE; ASCITES FLUID; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REACTIVATION; ENZYME SPECIFICITY; FEMALE; FUCOSYLATION; HUMAN; OVARY CANCER; PROTEIN ANALYSIS; PROTEIN ISOLATION;

ALEURIA AURANTIA; TETRAGONOLOBUS;

EID: 4544255009     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ørntoft TF, Vestergaard EM: Clinical aspects of altered glycosylation in cancer. Electrophoresis 1999, 20, 362-371.
2. Scanlin TF, Glick MC: Terminal glycosylation and disease: Influence on cancer and cystic fibrosis. Glycoconj J 2000, 17, 617-626.
3. Ivanova R, Soares P, Castro P, Sobrinho-Simoes M: Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of aggressive form of differentiated thyroid carcinoma. Virchows Arch 2002, 440, 418-424.
4. a and sialyl Tn antigens in gastric cancer patients. Anticancer Res 2002, 22, 451-458.
5. Sumikura S, Ishigami S, Natsugoe S, Miyazono F, Tokuda K, Nakajo A, Okumura H, Matsumoto M, Hokita S, Aikou T: Disseminated cancer cells in the blood and expression of sialylated antigen in gastric cancer. Cancer Let 2003, 200, 77-83.
6. Sharar SR, Winn RK, Harlan JM: The adhesion cascade and anti-adhesion therapy: an overview. Springer Semin Immunopathol 1995, 16, 359-378.
7. Bironaite D, Nesland JM, Dallen H, Risberg B, Bryne M: N-Glycans influence the in vitro adhesive and invasive behaviour of three metastatic cell lines. Tumor Biol 2000, 21, 165-175.
8. Ravindranath NMH, Nishimoto K, Chu K, Shuler C: Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy. Anticancer Res 2000, 20, 21-26.
9. Milović M, Popov I, Jelić S: Tumor markers in metastatic disease from cancer of unknown primary origin. Med Sci Monit 2002, 8, MT25-30.
10. Wołowiec D, Frydecka I, Kapelko-Słowik K, Potoczek S, Urbaniak-Kujda D, Kuliczkowski K: Blood serum levels of soluble forms of adhesion molecules ICAM I (slCAM-1) and selectin E (s-selectin E) in patients with various phases of non-Hodgins lymphomas. Med Sci Monit 2002, BR175-178.
11. Brown JR, Fuster MM, Whisenant T, Esko JD: Expression patterns of α2,3-sialyltransferases and α1,3 fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. J Biol Chem 2003, 278, 23352-23359.
12. 1-acid glycoprotein (orosomucoid) in health and disease: occurrence, regulation and possible functional implications. Trends Glycosci Glycotechnol 1998, 10, 235-245.
13. 1-antichymotrypsin and haptoglobin. Glycoconj J 1998, 15, 177-182.
14. x structures on purified glycoconjugates. Glycoconj J 1996, 13, 1043-1047.
15. Dargan E, Thompson S, Cantwell BMJ, Wilson RG, Turner GA: Changes in the fucose content of haptoglobin in breast and ovarian cancer: association with disease progression. Glycosyl & Dis 1994, 1, 37-43.
16. Haselhorst T, Weimar. T, Peters T: Molecular recognition of sialyl Lewis(x) and related saccharides by two lectins. J Amer Chem Soc 2001, 123, 10705-10714.
17. Yamashita K, Kochibe N, Ohkura T, Ueda I, Kobata A: Fractionation of L-fucose containing oligosaccharides on immobilized Aleuria aurantia lectin. J Biol Chem 1985, 260, 4688-4693.
18. x determinant. Glycoconj J 1997, 14, 45-55.
19. Loris R, De Greve H, Dao-Thi MH, Messens J, Imberty A, Wyns L: Structural basis of carbohydrate recognition by lectin II from Ulex europaeus, a protein with a promiscuous carbohydrate-binding site. J Mol Biol 2000, 301, 987-1002.
20. Dobryszycka W, Lisowska E: Effect of degradation on the chemical and biological properties of haptoglobin. I. Product of trypsin digestion. Biochim Biophys Acta 1966, 121, 42-49.
21. Katnik I, Jadach J, Krotkiewski H, Gerber J: Investigating the glycosylation of normal and ovarian cancer haptoglobins using digoxigenin-labelled lectins. Glycosyl & Dis 1994, 1, 97-104.
22. Ferens-Sieczkowska M, Olczak M: Carbohydrate structures of haptoglobin in sera of healthy people and a patient with congenital disorder of glycosylation. Z Naturforsch 2001, 56c, 122-131.
23. Goodarzi MT, Turner GA: A lectin-binding assay for the rapid characterization of the glycosylation of purified glycoproteins. In: The protein protocols handbook. Ed.: Walker JM, Humana Press Inc. Totowa, New Jersey 1996, 619-625.
24. Yamashita K, Koide N, Endo T, Iwaki Y, Kobata A: Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem 1989, 264, 2415-2423.
25. Kaila N, Thomas BE IV, Thakker P, Alvarez JC, Camphausen RT, Crommie D: Design and synthesis of sialyl Lewis x mimics as E-selecti inhibitors. Bioorg Med Chem Let 2001, 11, 151-155.
26. Thoma G, Bänthoma R, Jahnke W, Magnani JL, Patton JT: A readily available, highly potent E-selectin antagonist. Angew Chem Int Ed 2001, 40, 3644-3647.
27. Miyoshi E, Yukihiro K, Yamaguchi Y: The α1-6 fucosyltransferase gene and its biological significance. Biochim Biophys Acta 1999, 1473, 9-20.
28. Mita Y, Aoyagi Y, Suda T, Asakura H: Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein. J Hepatol 2000, 32, 946-954.
29. de Vries T, Knegtel RMA, Holmes EH, Macher BA: Fucosyltransferases: structure/function studies. Glycobiol 2001, 11, 119R-128R.
30. a expression is correlated with vascular invasion of human gallbladder adenocarcinoma. Int J Oncol 2000, 17, 55-60.